Revolution Medicines’ daraxonrasib wins positive EU CHMP opinion
The CHMP recommended marketing authorization in the European Union for metastatic pancreatic cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.